Emergent Biosolutions Inc (EBS) has fallen Tuesday morning, with the stock declining -5.92% in pre-market trading to 34.5. EBS's short-term technical score of 83 indicates that the stock has traded more bullishly over the last month than 83% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 141 out of 146 industries, Emergent Biosolutions Inc ranks higher than 94% of stocks. Emergent Biosolutions Inc has fallen 1.58% over the past month, closing at $37.02 on April 26. During this period of time, the stock fell as low as $27.97 and as high as $38.37. EBS has an average analyst recommendation of Buy. The company has an average price target of $48.17.
EBS has an Overall Score of 49. Find out what this means to you and get the rest of the rankings on EBS!